NASDAQ: $UNCY Pivotal For The People: An Exciting Clinical Trial & An Interview With UNCY's EVP!
Benzinga
2023-02-14
Views 3
Unicycive Therapeutics Inc is a biotechnology company dedicated to developing treatments for certain medical conditions. It is focusing on kidney diseases. The company's lead drug, Renazorb, is a novel phosphate-binding agent being developed for the treatment of hyperphosphatemia in chronic kidney disease (CKD) patients.
Report form
RELATED VIDEOS
